Separate terms with OR to return results that match either term.
 
Clear All
10,000 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date (Ascending) Status
70934-0543-05 70934-0543 Prednisone PREDNISONE 50.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Feb. 10, 2020 April 30, 2023 No Longer Used
52584-0414-01 52584-0414 Metoclopramide Hydrochloride Metoclopramide 5.0 mg/mL Ancillary Therapy Antiemetic Dopamine-2 Receptor Antagonist Intramuscular, Intravenous Sept. 13, 2016 May 1, 2023 No Longer Used
68788-7892-01 68788-7892 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral April 23, 2021 May 30, 2023 No Longer Used
68788-7892-03 68788-7892 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral April 23, 2021 May 30, 2023 No Longer Used
68788-7892-06 68788-7892 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral April 23, 2021 May 30, 2023 No Longer Used
68788-7892-09 68788-7892 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral April 23, 2021 May 30, 2023 No Longer Used
51862-0332-01 51862-0332 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral Aug. 3, 2016 May 31, 2023 No Longer Used
51862-0333-01 51862-0333 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral Aug. 3, 2016 May 31, 2023 No Longer Used
00703-4714-01 00703-4714 Topotecan Topotecan 1.0 mg/mL Chemotherapy Topoisomerase I Inhibitor Camptothecin Analogs Intravenous May 21, 2013 May 31, 2023 No Longer Used
00703-4714-71 00703-4714 Topotecan Topotecan 1.0 mg/mL Chemotherapy Topoisomerase I Inhibitor Camptothecin Analogs Intravenous May 21, 2013 May 31, 2023 No Longer Used
00703-4402-11 00703-4402 Vincristine Sulfate Vincasar PFS 1.0 mg/mL Chemotherapy Antimitotic Agent Vinca Alkaloid Intravenous May 1, 2000 May 31, 2023 No Longer Used
48818-0001-01 48818-0001 Pralatrexate Folotyn 20.0 mg/mL Chemotherapy Antimetabolite Folic Acid Analog Intravenous Sept. 24, 2009 June 30, 2023 No Longer Used
00173-0712-04 00173-0712 Dutasteride Avodart 0.5 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Dec. 10, 2002 June 30, 2023 No Longer Used
00173-0712-15 00173-0712 Dutasteride Avodart 0.5 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Dec. 10, 2002 June 30, 2023 No Longer Used
00378-2512-78 00378-2512 Capecitabine Capecitabine 500.0 mg/1 Chemotherapy Antimetabolite Pyrimidine Analog Oral Aug. 8, 2014 June 30, 2023 No Longer Used
48102-0047-01 48102-0047 Dexamethasone Dexamethasone 4.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral June 1, 2018 June 30, 2023 No Longer Used
42291-0768-01 42291-0768 Prednisone Prednisone 2.5 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral April 22, 2020 June 30, 2023 In Use
45963-0621-51 45963-0621 Fludarabine phosphate Fludarabine phosphate 25.0 mg/mL Chemotherapy Antimetabolite Purine Analog Intravenous March 2, 2017 June 30, 2023 No Longer Used
51079-0582-05 51079-0582 Leucovorin Calcium Leucovorin Calcium 25.0 mg/1 Ancillary Therapy Chemoprotective Antidote Oral Aug. 27, 1997 June 30, 2023 No Longer Used
51991-0377-05 51991-0377 IMATINIB MESYLATE IMATINIB MESYLATE 400.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral Feb. 8, 2019 June 30, 2023 No Longer Used
51991-0377-33 51991-0377 IMATINIB MESYLATE IMATINIB MESYLATE 400.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral Feb. 8, 2019 June 30, 2023 No Longer Used
51991-0377-90 51991-0377 IMATINIB MESYLATE IMATINIB MESYLATE 400.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral Feb. 8, 2019 June 30, 2023 No Longer Used
76388-0713-25 76388-0713 Busulfan Myleran 2.0 mg/1 Chemotherapy Alkylating Agent Alkylsulfonate Oral March 21, 1985 June 30, 2023 No Longer Used
68001-0482-25 68001-0482 Palonosetron Hydrochloride Palonosetron 0.25 mg/5mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous Jan. 25, 2021 June 30, 2023 No Longer Used
63629-2068-01 63629-2068 IMATINIB MESYLATE IMATINIB MESYLATE 400.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral Feb. 8, 2019 June 30, 2023 No Longer Used

Found 10,000 results in 5 milliseconds — Export these results